Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) (Q96178865)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19)
clinical trial

    Statements

    CovILD (English)
    0 references
    Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (English)
    0 references
    0 references
    29 April 2020
    0 references
    28 April 2022
    0 references
    130
    0 references
    18 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit